Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration
{"PURPOSE:":[0],"Microhematuria":[1],"may":[2,246],"be":[3],"a":[4,31,69,136,166],"sign":[5],"of":[6,12,27,34,42,51,77,120,132,176,179,191,203,213],"underlying":[7],"genitourinary":[8],"pathology,":[9],"but":[10],"diagnoses":[11],"bladder":[13,28,71,113,138,168,181,216],"cancer":[14,29,72,139,169,182,217],"are":[15],"rare":[16],"among":[17,231],"those":[18],"who":[19],"complete":[20],"evaluations.":[21],"This":[22],"study":[23],"determines":[24],"the":[25,39,48,56,117,128,192],"incidence":[26],"in":[30],"large":[32],"cohort":[33],"patients":[35,125,204],"with":[36,80,96,126,165,221],"microhematuria,":[37,127],"assesses":[38],"diagnostic":[40,244],"potential":[41],"current":[43,193],"guideline":[44],"recommendations,":[45],"and":[46,111,135,147,160,198],"characterizes":[47],"relative":[49,239],"risks":[50],"clinicodemographic":[52,109,224],"factors":[53],"to":[54,91,104],"inform":[55],"need":[57],"for":[58,116,173,200,250],"microhematuria":[59],"evaluation.":[60,251],"MATERIALS":[61],"AND":[62],"METHODS:":[63],"microhematuria.":[64,81],"The":[65,99],"main":[66],"outcome":[67],"was":[68,102,185],"new":[70,137,167],"diagnosis":[73,140,170],"within":[74],"2":[75],"years":[76],"index":[78],"urinalysis":[79],"Patients":[82],"were":[83,141,163],"stratified":[84],"by":[85,208],"American":[86],"Urologic":[87],"Association":[88],"risk":[89,94,119,175,218],"categories":[90],"compare":[92],"guideline-based":[93],"classification":[95],"model-based":[97],"estimation.":[98],"Fine-Gray":[100],"method":[101],"used":[103],"estimate":[105],"adjusted":[106,172],"associations":[107],"between":[108],"characteristics":[110],"incident":[112],"cancer,":[114],"accounting":[115],"competing":[118,174],"death.":[121,177],"RESULTS:":[122],"Among":[123],"267,133":[124],"two-year":[129],"cumulative":[130],"incidences":[131],"cystoscopy":[133],"completion":[134],"11.9%":[142],"(95%":[143,149],"CI":[144,150],"11.7,":[145],"12.0)":[146],"1.5%":[148],"1.4,":[151],"1.5),":[152],"respectively.":[153],"Older":[154],"age,":[155],"male":[156],"sex,":[157],"smoking":[158],"history,":[159],"≥25":[161],"RBC/hpf":[162],"associated":[164],"when":[171],"Performance":[178],"our":[180],"prediction":[183],"model":[184],"better":[186],"(ROC":[187],"AUC=0.63)":[188],"than":[189],"that":[190,237],"AUA":[194,209],"guidelines":[195],"(AUC=0.52,":[196],"p<0.001)":[197],"allowed":[199],"further":[201],"risk-estimation":[202],"designated":[205],"\\"high":[206,232],"risk\\"":[207,233],"criteria.":[210],"CONCLUSIONS:":[211],"Estimation":[212],"patient-level":[214],"microhematuria-related":[215],"is":[219],"possible":[220],"readily":[222],"available":[223],"factors.":[225],"Current":[226],"approaches":[227,236],"lack":[228],"nuance,":[229],"particularly":[230],"patients.":[234],"Precision":[235],"use":[238],"risk-factor":[240],"weights":[241],"and/or":[242],"novel":[243],"tools":[245],"improve":[247],"individualized":[248],"decision-making":[249]}
Authors
- Vincent D'Andrea (ORCID: https://orcid.org/0000-0001-9343-8092)
- Ekaterina Shishova
- Richard S. Matulewicz (ORCID: https://orcid.org/0000-0003-0757-0885)
- Danielle Candelieri-Surette (ORCID: https://orcid.org/0009-0008-8750-6720)
- Scott E Sherman (ORCID: https://orcid.org/0000-0001-9621-692X)
- Patrick R. Alba (ORCID: https://orcid.org/0000-0002-5176-5447)
- Samuel Gold (ORCID: https://orcid.org/0000-0002-9850-3938)
- Bernard H. Bochner (ORCID: https://orcid.org/0000-0003-0846-0848)
- Fady Baky
- Danil V. Makarov
- Andrew Nicholson
- Amy L. Voorhees
- Julie A. Lynch
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of Utah (US)
- VA NY Harbor Healthcare System (US)
- NYU Langone Health (US)
- VA Salt Lake City Healthcare System (US)
Publication Details
- Journal
- The Journal of Urology
- Published
- 2026-09-16
- DOI
- https://doi.org/10.1097/ju.0000000000005312
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00